11Feb/13

Life Technologies Receives FDA 510(k) Clearance for Diagnostic Use of Sanger … – PR Newswire (press release)

Life Technologies Receives FDA 510(k) Clearance for Diagnostic Use of Sanger
PR Newswire (press release)
11, 2013 /PRNewswire/ — Life Technologies Corporation (NASDAQ: LIFE) today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore® HLA typing kits. The development

and more »

10Feb/13

醫言有理﹕乙型地中海貧血症 – 雅虎香港

醫言有理﹕乙型地中海貧血症
雅虎香港
小晴有一位哥哥,他們的白血球血型(HLA typing)相同,可進行骨髓移植。手術雖有風險,但可根治地貧症,免除終身輸血打針之苦。 百分之三的香港人有乙型地貧症的基因變化,大家要留心。 作者為血液及血液腫瘤科專科醫生,行醫逾卅年,依然滿腔熱血. 文:梁憲孫

10Feb/13

醫言有理﹕乙型地中海貧血症 – 明報

醫言有理﹕乙型地中海貧血症
明報
小晴有一位哥哥,他們的白血球血型(HLA typing)相同,可進行骨髓移植。手術雖有風險,但可根治地貧症,免除終身輸血打針之苦。 百分之三的香港人有乙型地貧症的基因變化,大家要留心。 作者為血液及血液腫瘤科專科醫生,行醫逾卅年,依然滿腔熱血. 文:梁憲孫

and more »

24Jan/13

One Lambda, Inc., Now Part of Thermo Fisher Scientific, Obtained FDA … – PharmiWeb.com (press release)

One Lambda, Inc., Now Part of Thermo Fisher Scientific, Obtained FDA
PharmiWeb.com (press release)
Product families used in conjunction with HLA Fusion include the market-leading LABScreen® (antibody detection) and LABType® (HLA Typing) products, in addition to LAT™, LCT™, FlowPRA®, and MicroSSP™ products. The HLA Fusion Software

and more »

21Jan/13

신장이식 공여자와 수혜자 수술 전 증례보고 컨퍼런스 – 청년의사

신장이식 공여자와 수혜자 수술 전 증례보고 컨퍼런스
청년의사
HLA typing 검사 결과, 수혜자는 A2, A31, B13, B51, DR8, DR12였고 공여자는 A31, A33, B44, B51, DR8, DR13으로, 두 사람 간 HLA 불일치는 A(1), B(1), DR(1)이며, 2012년 12월 13일 수술 예정에 있다. 최석진: 영상 판독 결과상, 공장(jejunum) 쪽으로 가는 혈관